{{Rsnum
|rsid=3757441
|Chromosome=7
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=EZH2
|position=148827660
|Gene_s=EZH2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 9.7 | 28.3 | 61.9
| HCB | 5.9 | 35.3 | 58.8
| JPT | 7.1 | 42.0 | 50.9
| YRI | 0.0 | 10.9 | 89.1
| ASW | 0.0 | 19.3 | 80.7
| CHB | 5.9 | 35.3 | 58.8
| CHD | 3.7 | 34.9 | 61.5
| GIH | 6.0 | 30.0 | 64.0
| LWK | 0.9 | 19.1 | 80.0
| MEX | 3.4 | 31.0 | 65.5
| MKK | 3.8 | 31.4 | 64.7
| TSI | 7.8 | 31.4 | 60.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=24040354
|Title=Effects of EZH2 polymorphisms on susceptibility to and pathological development of hepatocellular carcinoma
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}